Tobam Sells 3,734 Shares of The Allstate Co. (NYSE:ALL)

Tobam lessened its position in shares of The Allstate Co. (NYSE:ALLFree Report) by 64.9% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 2,016 shares of the insurance provider’s stock after selling 3,734 shares during the period. Tobam’s holdings in Allstate were worth $389,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also made changes to their positions in the company. Sumitomo Mitsui DS Asset Management Company Ltd grew its holdings in shares of Allstate by 2.3% during the 4th quarter. Sumitomo Mitsui DS Asset Management Company Ltd now owns 35,611 shares of the insurance provider’s stock valued at $6,865,000 after purchasing an additional 803 shares during the last quarter. Sumitomo Mitsui Trust Group Inc. grew its stake in shares of Allstate by 9.1% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 709,855 shares of the insurance provider’s stock worth $136,853,000 after buying an additional 59,474 shares during the last quarter. Strategic Financial Concepts LLC increased its holdings in shares of Allstate by 15,062.3% during the fourth quarter. Strategic Financial Concepts LLC now owns 1,119,129 shares of the insurance provider’s stock worth $215,757,000 after buying an additional 1,111,748 shares in the last quarter. Buck Wealth Strategies LLC bought a new position in shares of Allstate in the 4th quarter valued at $283,000. Finally, Bleakley Financial Group LLC boosted its holdings in shares of Allstate by 13.0% during the 4th quarter. Bleakley Financial Group LLC now owns 6,600 shares of the insurance provider’s stock valued at $1,272,000 after acquiring an additional 760 shares in the last quarter. Institutional investors and hedge funds own 76.47% of the company’s stock.

Allstate Stock Down 0.9 %

Allstate stock opened at $190.24 on Friday. The stock has a market cap of $50.37 billion, a PE ratio of 12.32, a price-to-earnings-growth ratio of 1.47 and a beta of 0.52. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.40 and a current ratio of 0.40. The firm’s 50-day simple moving average is $192.75 and its 200 day simple moving average is $188.86. The Allstate Co. has a fifty-two week low of $153.87 and a fifty-two week high of $209.88.

Allstate (NYSE:ALLGet Free Report) last posted its quarterly earnings data on Wednesday, February 5th. The insurance provider reported $7.67 earnings per share for the quarter, topping the consensus estimate of $5.40 by $2.27. Allstate had a return on equity of 26.67% and a net margin of 6.77%. Research analysts predict that The Allstate Co. will post 16.96 EPS for the current fiscal year.

Allstate Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, January 2nd. Investors of record on Friday, November 29th were issued a dividend of $0.92 per share. The ex-dividend date of this dividend was Friday, November 29th. This represents a $3.68 dividend on an annualized basis and a yield of 1.93%. Allstate’s dividend payout ratio (DPR) is presently 23.83%.

Analyst Upgrades and Downgrades

ALL has been the topic of several recent research reports. BMO Capital Markets lifted their target price on shares of Allstate from $205.00 to $214.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Piper Sandler upped their target price on Allstate from $206.00 to $244.00 and gave the company an “overweight” rating in a research report on Tuesday, November 26th. Evercore ISI upgraded shares of Allstate from an “in-line” rating to an “outperform” rating in a report on Wednesday, January 8th. UBS Group upped their price target on Allstate from $216.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, November 4th. Finally, Jefferies Financial Group raised their price objective on Allstate from $231.00 to $267.00 and gave the company a “buy” rating in a research note on Friday, November 8th. One equities research analyst has rated the stock with a sell rating, one has given a hold rating, fourteen have issued a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the stock presently has an average rating of “Moderate Buy” and an average target price of $218.13.

Get Our Latest Research Report on Allstate

Allstate Company Profile

(Free Report)

The Allstate Corporation, together with its subsidiaries, provides property and casualty, and other insurance products in the United States and Canada. It operates in five segments: Allstate Protection; Protection Services; Allstate Health and Benefits; Run-off Property-Liability; and Corporate and Other segments.

Recommended Stories

Institutional Ownership by Quarter for Allstate (NYSE:ALL)

Receive News & Ratings for Allstate Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allstate and related companies with MarketBeat.com's FREE daily email newsletter.